Ocular Dorzolamide Nanoliposomes for Prolonged IOP Reduction: in-vitroand in-vivo Evaluation in Rabbits

Dorzolamide ophthalmic drop is one of the most common glaucoma medications but it has a short residence time in the eye. The aim of this study is to develop ocular dorzolamide HCl nanoliposomes (DRZ – nanoliposomes) and to evaluate their potential use for the treatment of ocular hypertension. Nanoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouchak, Maryam, Bahmandar, Reza, Bavarsad, Neda, Farrahi, Fereydoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986113/
https://www.ncbi.nlm.nih.gov/pubmed/27610160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986113/
https://www.ncbi.nlm.nih.gov/pubmed/27610160

Ejemplares similares